These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19543577)

  • 1. Abnormal hematological indices in cirrhosis.
    Qamar AA; Grace ND
    Can J Gastroenterol; 2009 Jun; 23(6):441-5. PubMed ID: 19543577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does portal hypertension contribute to the pathogenesis of gastric ulcer associated with liver cirrhosis?
    Kitano S; Dolgor B
    J Gastroenterol; 2000; 35(2):79-86. PubMed ID: 10680661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly.
    Lv Y; Yee Lau W; Wu H; Han X; Gong X; Liu N; Yue J; Li Q; Li Y; Deng J
    Exp Biol Med (Maywood); 2017 Apr; 242(7):744-749. PubMed ID: 28299974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indications for splenectomy in cirrhosis].
    Lorriaux A; Gentit F
    Sem Hop; 1970 Sep; 46(37):2337-40. PubMed ID: 4319022
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prognosis of hepatic cirrhosis in relation to clinical and biological parameters and the degree of portal hypertension].
    González Reyes A; González Reimers CE; Santolaria Fernández F; Hernández García MT; Pestana Pestana M; Batista López N; Jorge Hernández JA; Cubillo Ferreira G; Hernández Nieto L
    Rev Esp Enferm Apar Dig; 1987 Apr; 71(4):286-92. PubMed ID: 3496633
    [No Abstract]   [Full Text] [Related]  

  • 6. Portal hypertensive colopathy in patients with liver cirrhosis.
    Ito K; Shiraki K; Sakai T; Yoshimura H; Nakano T
    World J Gastroenterol; 2005 May; 11(20):3127-30. PubMed ID: 15918202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of ascites in cirrhosis.
    Arroyo V; Badalamenti S; Ginès P
    Minerva Med; 1987 May; 78(10):645-50. PubMed ID: 3587709
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value.
    Körner T; Kropf J; Gressner AM
    J Hepatol; 1996 Nov; 25(5):684-8. PubMed ID: 8938546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Splenic blood circulation in liver cirrhosis with portal hypertension syndrome].
    Bulanov KI
    Klin Khir; 1998; (8):29-31. PubMed ID: 9866318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
    La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC
    Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of autonomic dysfunction in cirrhotic and noncirrhotic portal hypertension.
    Rangari M; Sinha S; Kapoor D; Mohan JC; Sarin SK
    Am J Gastroenterol; 2002 Mar; 97(3):707-13. PubMed ID: 11922567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyponatremia in Liver Cirrhosis].
    Jang CM; Jung YK
    Korean J Gastroenterol; 2018 Aug; 72(2):74-78. PubMed ID: 30145859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical study on the relationship between hematocytopenia and splenomegaly caused by cirrhotic portal hypertension.
    Lv Y; Gong X; Xie X; Wang B; Yang Y; Li Y
    Cell Biochem Biophys; 2014 Sep; 70(1):355-60. PubMed ID: 24696075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic cholangiojejunostomy in a case of biliary cirrhosis with portal hypertension.
    DE ANDRADE MA; MARTINS E SILVA R
    Surgery; 1956 Nov; 40(5):913-21. PubMed ID: 13371455
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diabetes mellitus secondary to liver diseases. A review (author's transl)].
    Guillon J; Charbonnel B
    Diabete Metab; 1975 Sep; 1(3):191-9. PubMed ID: 791727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver cirrhosis.
    Pinzani M; Rosselli M; Zuckermann M
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):281-90. PubMed ID: 21497745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor in patients with schistosomal and/or viral liver diseases and portal hypertension.
    Abdel Rahman M; Eid SA; Abdel Rahman A; Nasr G; Morsy TA
    J Egypt Soc Parasitol; 2000 Apr; 30(1):233-43. PubMed ID: 10786034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension.
    Garcia-Tsao G; Bosch J; Kayali Z; Harrison SA; Abdelmalek MF; Lawitz E; Satapathy SK; Ghabril M; Shiffman ML; Younes ZH; Thuluvath PJ; Berzigotti A; Albillos A; Robinson JM; Hagerty DT; Chan JL; Sanyal AJ;
    J Hepatol; 2020 May; 72(5):885-895. PubMed ID: 31870950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cirrhosis and Portal Hypertension in the Pediatric Population.
    Chapin CA; Bass LM
    Clin Liver Dis; 2018 Nov; 22(4):735-752. PubMed ID: 30266160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical therapy of portal hypertension in cirrhosis].
    BAEV B; T'ANG WZ
    Khirurgiia (Sofiia); 1959; 12():415-21. PubMed ID: 13795713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.